Redsense Medical

On May 5, 2023, Reps. Adrian Smith (R-NE) and Melanie Stansbury (D-NM) introduced the Home Dialysis Risk Prevention Act. The legislation ensures that patients undergoing home dialysis have access to blood loss detection devices that will alert them if blood loss from venous needle dislodgement (VND) is detected.

"We are pleased that US House of Representatives is addressing patient safety for hemodialysis at home with this this important bill. Redsense's focus is on providing increased patient safety for home hemodialysis. We look forward to the advancement of this bill." says Pontus Nobréus CEO of Redsense Medical.

Further information about the bill can be found through the link: https://adriansmith.house.gov/media/press-releases/smith-stansbury-introduce-bipartisan-bill-improve-home-dialysis-patient-safety

About venous needle dislodgement (VND)

During hemodialysis, the patient's bloodstream is connected to an artificial kidney machine outside of the body using vascular access. The purified blood is returned to the patient through venous needle access. If the venous needle dislodges, the patient loses a lot of blood quickly if it is not immediately detected. Unpredictable VND can happen to any dialysis patient, at any time. VND has been estimated to occur more than 300 times a day in the United States alone and poses a serious safety risk for the patient.